Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Phosphate Tolerance in CKD
NCT02672293Completed
- Start
- Jan 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sodium phosphate. Primary endpoint: Fractional excretion of phosphate at 2 hours. Started Jan 2013; status: completed.
02
Drugs
sodium phosphate
Beyond the preview
Go deeper on NCT02672293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02672293.